Keyphrases
Cyclic GMP
100%
Estrogen Receptor
100%
ICI 182,780
100%
Thioredoxin
100%
Neuroprotection
100%
17β-estradiol
100%
NOS1
42%
Estrogen
28%
Oxidative Stress
28%
Cell Viability
28%
Lipid Peroxidation
14%
Antioxidant System
14%
Molecular Mechanism
14%
Receptor-mediated
14%
Cell Death
14%
Receptor Antagonist
14%
Caspase-3
14%
Neurodegeneration
14%
Neuronal Nitric Oxide Synthase (nNOS)
14%
SH-SY5Y Cells
14%
Manganese Superoxide Dismutase (MnSOD)
14%
Anti-apoptotic
14%
Pro-apoptotic
14%
Physiological Concentrations
14%
Thioredoxin 1 (Trx1)
14%
Serum Deprivation
14%
Brain-derived Neurotrophic Factor
14%
7-nitroindazole
14%
Guanylate Cyclase
14%
CGMP-dependent Protein Kinase
14%
Heme oxygenase-2
14%
Thioredoxin Reductase Inhibitor
14%
Alzheimer Patients
14%
4-nitrobenzoic Acid
14%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Diethylstilbestrol
100%
Neuroprotection
100%
Thioredoxin
100%
Cyclic GMP
100%
Cell Viability
28%
Receptor
14%
Clinical Study
14%
Receptor Antagonist
14%
Caspase 3
14%
Nerve Degeneration
14%
Antioxidant
14%
Antiapoptotic
14%
Cytoprotective Agent
14%
Neuronal Nitric Oxide Synthase
14%
Cyclic GMP Dependent Protein Kinase
14%
Thioredoxin 1
14%
Brain Derived Neurotrophic Factor
14%
Thioredoxin Reductase
14%
Neuroscience
Cyclic Guanosine Monophosphate
100%
CGMP-dependent Protein Kinase
14%
7-Nitroindazole
14%
Guanylate Cyclase
14%